We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-12.34%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$111M
AUM Growth
+$65.4M
Cap. Flow
+$21.2M
Cap. Flow %
19.2%
Top 10 Hldgs %
96.91%
Holding
38
New
10
Increased
9
Reduced
4
Closed
15
Avg Time Held Equity + Options
3 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
2.1 quarters
Avg Time Held Equity only
1.3 quarters
Top 10 Avg Time Held Equity only
0.2 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
PAVS icon
Paranovus Entertainment Technology
PAVS
+$8.07M
2
TOYO icon
TOYO Co
TOYO
+$6.19M
3
FAMI icon
Farmmi Inc
FAMI
+$4.28M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.01M
5
CRVO icon
CervoMed
CRVO
+$877K

Top Sells

Rank Stock Value
1
ALP
Alpha Compute
ALP
+$655K
2
DSY icon
Big Tree Cloud Holdings
DSY
+$337K
3
TC icon
TuanChe
TC
+$242K
4
CPOP icon
Pop Culture Group
CPOP
+$201K
5
INM icon
InMed Pharmaceuticals
INM
+$194K

Sector Composition

Rank Sector Weight
1 Miscellaneous 93%
2 Technology 3.17%
3 Healthcare 2.02%
4 Consumer Staples 1.27%
5 Utilities 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$54.1M 48.99%
725
+278
+62% +$202K
2022 Q2
16 quarters
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$15.3M 13.85%
+205
New +$149K
2026 Q2
0 quarters
OEF icon
3
CALL
iShares S&P 100 ETF
OEF
$20.8B
$13.3M 12.02%
+442
New +$158K
2026 Q2
0 quarters
OEF icon
4
PUT
iShares S&P 100 ETF
OEF
$20.8B
$13.2M 11.99%
441
+141
+47% +$50.5K
2020 Q1
25 quarters
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$4.11M 3.72%
5,500
+2,766
+101% +$2.01M
2025 Q4
2 quarters
TOYO icon
6
TOYO Co
TOYO
$184M
$3.5M 3.17%
+503,846
New +$6.19M
2026 Q2
0 quarters
ABVX icon
7
CALL
Abivax
ABVX
$7.59B
$1.09M 0.99%
82
+5
+6% +$566
2025 Q4
2 quarters
FAMI icon
8
Farmmi Inc
FAMI
$4.16M
$840K 0.76%
+3,515,929
New +$4.28M
2026 Q2
0 quarters
SIDU icon
9
PUT
Sidus Space
SIDU
$146M
$816K 0.74%
2,905
+1,856
+177% +$7.11K
2026 Q1
1 quarter
CRVO icon
10
CervoMed
CRVO
$37.9M
$772K 0.7%
+248,880
New +$877K
2026 Q2
0 quarters
ZVRA icon
11
PUT
Zevra Therapeutics
ZVRA
$672M
$612K 0.55%
427
+87
+26% +$967
2024 Q4
6 quarters
TPST icon
12
Tempest Therapeutics
TPST
$12.5M
$568K 0.51%
511,286
+493,430
+2,763% +$814K
2025 Q4
2 quarters
PAVS icon
13
Paranovus Entertainment Technology
PAVS
$2.98M
$561K 0.51%
+75,440
New +$8.07M
2026 Q2
0 quarters
BIAF icon
14
bioAffinity Technologies
BIAF
$2.34M
$297K 0.27%
+24,376
New +$747K
2026 Q2
0 quarters
CREG icon
15
DELISTED
Smart Powerr
CREG
$263K 0.24%
+127,774
New +$541K
2026 Q2
0 quarters
BCTX icon
16
Briacell Therapeutics
BCTX
$33.7M
$262K 0.24%
80,721
+6,806
+9% +$25.1K
2026 Q1
1 quarter
REVB icon
17
Revelation Biosciences
REVB
$3.09M
$217K 0.2%
210,582
+111,150
+112% +$121K
2025 Q2
4 quarters
SNES icon
18
SenesTech
SNES
$3.51M
$211K 0.19%
141,756
-76,777
-35% -$125K
2025 Q3
3 quarters
BCTXL icon
19
BriaCell Therapeutics Warrant
BCTXL
$2.85M
$169K 0.15%
190,383
-190,303
-50% -$176K
2026 Q1
1 quarter
SIDU icon
20
Sidus Space
SIDU
$146M
$122K 0.11%
+43,377
New +$166K
2026 Q2
0 quarters
INM icon
21
InMed Pharmaceuticals
INM
$7.47M
$69.7K 0.06%
44,970
-175,290
-80% -$194K
2025 Q3
3 quarters
NUWE icon
22
Nuwellis
NUWE
$2.13M
$49.9K 0.05%
+16,372
New +$447K
2026 Q2
0 quarters
BCTXZ icon
23
BriaCell Therapeutics Corp Warrant
BCTXZ
$501K
$11.5K 0.01%
120,802
-85,951
-42% -$8.36K
2025 Q2
4 quarters
BNBX
24
DELISTED
BNB PLUS CORP
BNBX
– –
-13,541
Closed -$8.67K –
BDRX icon
25
Biodexa Pharmaceuticals
BDRX
$394K
– –
-51,494
Closed -$159K –
1
2

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q2 2026 Portfolio in Review

As of Q2 2026, Sabby Management held 38 positions worth $111M, up 145% from $45.1M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Sabby Management deployed $21.2M of net new capital in Q2 2026, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was Paranovus Entertainment Technology: 75,440 shares worth $561K.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was InMed Pharmaceuticals, an estimated $194K trimmed.

  • Sabby Management's largest Q2 2026 buy was Paranovus Entertainment Technology: 75,440 shares worth $561K.
  • Sabby Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.01M increase.
  • Sabby Management's biggest Q2 2026 reduction was InMed Pharmaceuticals, cutting an estimated $194K.
  • Sabby Management fully exited Alpha Compute in Q2 2026, selling an estimated $655K.
  • Sabby Management's ten largest holdings make up 97% of its $111M portfolio in Q2 2026.
  • Sabby Management opened 10 new positions and closed 15 in Q2 2026.
  • Sabby Management's portfolio value rose 145% quarter-over-quarter to $111M.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.